Typically, 67% of cancer patients live for 5 or more years after diagnosis (Cancer.Net, 2021). During these years, it is common for their white blood cell count (WBC) to be lower due to the cancer and/ or medication they are being treated with. This can lead to lower quality of life as they are at higher risk of infection. (Mayo Clinic, 2022) In cancer treatment, infections come second as a major cause of death. About 60% of deaths among cancer patients are connected to infections. (American Society of Clinical Oncology, 2019)Carlos Castro Gonzales, founder of Leuko, is on a mission to improve the quality of life and outcomes for chemotherapy patients, through a light-based medical technology that counts white blood cells. In this episode, we talk about his journey building Leuko.Connect with us:Neuroute - copilot for clinical trials https://www.neuroute.co/Twitter: https://twitter.com/livialifesLinkedIn: http://www.linkedin.com/in/livialifesGuest: https://www.linkedin.com/in/ca....rlos-castro-gonzalez www.cancer.org/treatment/treat....ments-and-side-effec #MedicalTechnology #NeutropeniaCare #WhiteCellMonitoring #ceo